ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,567Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 262

$473K Total Retail Price of All Prescriptions

Rank: 27 out of 262

391 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 391 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 391 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 7,902 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
FUROSEMIDE 494 395 1 4
SIMVASTATIN 457 353 2 1
LISINOPRIL 357 288 3 3
LEVOTHYROXINE SODIUM 337 281 4 2
OMEPRAZOLE 324 207 5 5
HYDROCODONE-ACETAMINOPHEN 260 187 S3 6 15
POTASSIUM CHLORIDE 239 191 7 10
METOPROLOL SUCCINATE 231 208 8 11
AMLODIPINE BESYLATE 223 208 9 6
GABAPENTIN 221 176 10 19
METOPROLOL TARTRATE 218 187 11 8
SERTRALINE HCL 164 157 12 14
HYDROCHLOROTHIAZIDE 157 124 13 7
WARFARIN SODIUM 141 138 14 12
METFORMIN HCL 141 92 14 9
OXYCODONE HCL 124 64 S2 16 83
ALLOPURINOL 124 110 16 22
ATORVASTATIN CALCIUM 100 71 18 13
ZOLPIDEM TARTRATE 99 77 19 26
MELOXICAM 97 71 20 54
DIGOXIN 96 83 21 28
JANTOVEN 95 94 22 39
PREDNISONE 89 87 23 29
ZETIA 88 82 24 60
TRICOR 86 47 25 101
TRAMADOL HCL 86 53 25 18
CARVEDILOL 84 71 27 31
MIRTAZAPINE 83 66 28 35
OXYCODONE-ACETAMINOPHEN 79 19 S2 29 88
PROAIR HFA 73 45 30 53
DONEPEZIL HCL 73 73 30 23
FAMOTIDINE 71 62 32 65
ATENOLOL 68 68 33 16
DIOVAN 68 68 33 47
INSULIN SYRINGE 68 27 33 85
TAMSULOSIN HCL 65 63 36 25
LANTUS 64 36 37 51
CYCLOBENZAPRINE HCL 60 20 R 38 110
CRESTOR 59 41 39 30
CLOPIDOGREL 59 57 39 38
AZITHROMYCIN 59 32 39 44
TRAZODONE HCL 58 20 42 36
CARBIDOPA-LEVODOPA 58 58 42 66
ALENDRONATE SODIUM 57 57 44 21
FLUOXETINE HCL 56 22 45 46
METFORMIN HCL ER 56 44 45 63
NEXIUM 56 26 45 57
GLIPIZIDE 55 43 48 70
PHENYTOIN SODIUM EXTENDED 55 35 48 148
FENOFIBRATE 54 35 50 77
TRIAMTERENE-HCTZ 53 53 51 32
RISPERIDONE 52 52 52 50
CITALOPRAM HBR 51 33 53 20
SYMBICORT 51 32 53 174
LYRICA 51 23 53 86
LANTUS SOLOSTAR 50 22 56 49
LOSARTAN POTASSIUM 50 44 56 17
CYMBALTA 50 0 56 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 22, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.